Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000253678 | SCV000311873 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000253678 | SCV000341061 | benign | not specified | 2016-04-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000878330 | SCV001021218 | benign | Congenital primary aphakia; Anterior segment dysgenesis | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683064 | SCV001897460 | benign | not provided | 2020-03-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328744 | SCV002628627 | benign | Cardiovascular phenotype | 2019-04-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000253678 | SCV004029068 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000253678 | SCV001925975 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001683064 | SCV001972120 | likely benign | not provided | no assertion criteria provided | clinical testing |